Acrux Revenue and Competitors
Estimated Revenue & Valuation
- Acrux's estimated annual revenue is currently $24.7M per year.
- Acrux's estimated revenue per employee is $201,000
Employee Data
- Acrux has 123 Employees.
- Acrux grew their employee count by 21% last year.
Acrux's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CFO / Company Secretary | Reveal Email/Phone |
3 | Product Development & Technical Affairs Director | Reveal Email/Phone |
4 | Technical & Project Director | Reveal Email/Phone |
5 | Senior Project Manager | Reveal Email/Phone |
6 | Analytical Development Manager | Reveal Email/Phone |
7 | HR & Facilities Manager | Reveal Email/Phone |
8 | Regulatory Affairs Manager | Reveal Email/Phone |
9 | Project Manager | Reveal Email/Phone |
10 | technical affairs manager | Reveal Email/Phone |
Acrux Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Acrux?
Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising specialty and generic topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Marketed products include Axiron®, Evamist® and Lenzetto®. More recently, in addition to specialty products, Acrux has identified and initiated development of a range of generic products. Acrux is leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring more products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.
keywords:N/AN/A
Total Funding
123
Number of Employees
$24.7M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Acrux News
Tapemark, Acrux Limited Nitto Denko Corporation Skinvisible Pharmaceuticals, Inc. Mylan Pharmaceuticals Inc. Pocono Coated Products LLC
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17.8M | 123 | 16% | N/A |
#2 | $14.8M | 123 | 22% | N/A |
#3 | $17.8M | 123 | 16% | N/A |
#4 | $3.5M | 123 | 41% | N/A |
#5 | $33.2M | 123 | 24% | N/A |